An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.
about
Evaluation of Factors Influencing Antibody Reduction for Development of Antibody Drug ConjugatesStrategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design.
P2860
An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@en
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@nl
type
label
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@en
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@nl
prefLabel
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@en
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@nl
P2093
P2860
P1476
An anti-HER2 antibody conjugat ...... positive human gastric cancer.
@en
P2093
Changjiang Huang
Hongwen Li
Jianmin Fang
Jing Jiang
Liguang Lou
Xuejing Yao
P2860
P304
P356
10.1080/15384047.2016.1139248
P577
2016-02-06T00:00:00Z